Chemistry:Licofelone
From HandWiki
Short description: Analgesic and anti-inflammatory compound
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C23H22ClNO2 |
| Molar mass | 379.88 g·mol−1 |
| |
  (what is this?) (verify) | |
Licofelone is a dual COX/LOX inhibitor[1][2] that was studied in clinical trials as a treatment for osteoarthritis[3] and which was under development by Merckle GmbH with partners Alfa Wassermann and Lacer.
Licofelone is both an analgesic and an anti-inflammatory. Inhibition of 5-lipoxygenase (5-LOX) may reduce the gastrointestinal toxicity associated with other nonsteroidal anti-inflammatory drugs (NSAID), which only inhibit cyclooxygenase (COX). Licofelone is the first drug to inhibit both.
Phase III trials for osteoarthritis were conducted in the early 2000s,[4][5] but results were mixed and the drug has never been submitted for regulatory approval.
References
- ↑ "The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products". British Journal of Pharmacology 152 (4): 471–80. October 2007. doi:10.1038/sj.bjp.0707416. PMID 17704828.
- ↑ "Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis". The Journal of Pharmacology and Experimental Therapeutics 320 (1): 108–16. January 2007. doi:10.1124/jpet.106.110361. PMID 17015640.
- ↑ "Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis". Rheumatology 43 Suppl 1 (90001): i21-5. February 2004. doi:10.1093/rheumatology/keh105. PMID 14752172.
- ↑ "Licofelone – Novel Analgesic and Anti-Inflammatory Agent for Osteoarthritis". http://www.drugdevelopment-technology.com/projects/licofelone/.
- ↑ "Relationship between bone marrow lesions, cartilage loss and pain in knee osteoarthritis: results from a randomised controlled clinical trial using MRI". Annals of the Rheumatic Diseases 69 (12): 2118–24. December 2010. doi:10.1136/ard.2009.127993. PMID 20610445.
 |  |
